drugset / Trial / NCT05692570
A Study of PBI-200 With Ritonavir or Cobicistat in Healthy Volunteers
NaSingle-groupOpen-labelTreatment
Summary
This is a drug-drug interaction study in volunteers to evaluate the effect of ritonavir or cobicistat on the pharmacokinetics (PK) of PBI-200.
Timeline
- Start
- 2022-09-09
- Primary completion
- 2022-11-12
- Completion
- 2022-11-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cobicistat | Small molecule | — | Oral |
| Subject | PALTIMATRECTINIB | Small molecule | — | Oral |
| Subject | Ritonavir | Other / unclassified | — | Oral |
Indications
No indication recorded.